Thread: PS...from Lani
View Single Post
Old 04-11-2006, 03:00 PM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
PS...from Lani

In the case of Erbitux (another monoclonal antibody) and head and neck cancer, they feel that erbitux sensitizes the cancer cells to radiation therapy ie, the radiation therapy is able to kill more cancer cells and prevent recurrence better when the cells are simultaneously attacked and targeted by the monoclonal antibody

I will try to look up if there are any similar articles with Herceptin

I am sure you wouldn't mind getting "more bang for your buck"!

LANI
Lani is offline   Reply With Quote